@article{2989965,
    title = "Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic",
    author = "Chaves, A.L.F. and Castro, A.F. and Marta, G.N. and Junior, G.C. and Ferris, R.L. and Giglio, R.E. and Golusinski, W. and Gorphe, P. and Hosal, S. and Leemans, C.R. and Magné, N. and Mehanna, H. and Mesía, R. and Netto, E. and Psyrri, A. and Sacco, A.G. and Shah, J. and Simon, C. and Vermorken, J.B. and Kowalski, L.P.",
    journal = "Oral Oncology",
    year = "2020",
    volume = "107",
    publisher = "Elsevier Ireland Ltd",
    issn = "1368-8375",
    doi = "10.1016/j.oraloncology.2020.104734",
    keywords = "cisplatin, advanced cancer;  cancer palliative therapy;  cancer patient;  cancer radiotherapy;  cancer recurrence;  cancer surgery;  chemoradiotherapy;  coronavirus disease 2019;  decision making;  early cancer;  Editorial;  emergency;  fiberscope endoscopy;  follow up;  head and neck squamous cell carcinoma;  head and neck surgery;  health care quality;  high risk patient;  human;  hypofractionated radiotherapy;  induction chemotherapy;  metastasis;  multidisciplinary team;  multimodality cancer therapy;  pandemic;  personalized medicine;  postoperative care;  practice guideline;  priority journal;  recurrent disease;  Severe acute respiratory syndrome coronavirus 2;  surgical margin;  Betacoronavirus;  complication;  Coronavirus infection;  disease transmission;  global disease burden;  head and neck tumor;  infection control;  oncology;  pandemic;  pathogenicity;  practice guideline;  prevention and control;  public health;  risk factor;  treatment outcome;  virus pneumonia, Betacoronavirus;  Coronavirus Infections;  Emergencies;  Global Burden of Disease;  Head and Neck Neoplasms;  Humans;  Infection Control;  Infectious Disease Transmission, Patient-to-Professional;  Infectious Disease Transmission, Professional-to-Patient;  Medical Oncology;  National Health Programs;  Pandemics;  Pneumonia, Viral;  Practice Guidelines as Topic;  Risk Factors;  Treatment Outcome"
}